Core Viewpoint - Hang Seng Bank announced a share buyback of 200,000 shares at a cost of HKD 22.89 million on August 7 [1] Group 1 - The company executed a buyback program, indicating a strategy to enhance shareholder value [1] - The total expenditure for the buyback was HKD 22.89 million, reflecting the company's commitment to returning capital to shareholders [1] - The number of shares repurchased was 200,000, which may influence the stock's liquidity and market perception [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 恒生銀行有限公司 呈交日期： 2025年8月7日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | | 00011 | 說明 | 股份 | | | | | | 多櫃檯證券代號 | | 80011 | RMB 說明 | 股份 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | 已發行股份（不包 ...

香港银行股午后走高，截至发稿，渣打集团(02888)涨4.09%，报4.09%，报147.7港元；东亚银行(00023) 涨2.32%，报12.78港元；汇丰控股(00005)涨1.96%，报98.9港元；恒生银行(00011)涨1.77%，报115.1港 元。 消息面上，汇丰、恒生、渣打近日发布上半年业绩。华泰证券指出，渣打、汇丰扣非后业绩均超市场预 期，其中上半年非息收入表现亮眼，为营收增长提供主要支撑。但香港银行整体风险仍存，一方面 HIBOR持续低位导致息差下行，对二季度净利息收入造成拖累；另一方面香港信贷需求仍然疲软，渣 打、汇丰二季度本地贷款均环比收缩，此外香港商业地产不良率环比提升，地产行业压力持续。 此外，8月6日，因港元汇率触及7.85港元兑1美元的"弱方兑换保证"，香港金管局买入84.39亿港元，沽 出美元。银行体系总结余将于8月8日降至640.62亿港元。据悉，这已经是香港金管局在7天内的第4次干 预。香港金管局还表示，未来若"弱方兑换保证"再被触发，香港金管局将继续按机制买入港元，银行总 结余下降将逐步推高拆息。 本文源自：智通财经网 ...

Core Viewpoint - Hong Kong bank stocks have risen in the afternoon trading session, with Standard Chartered, HSBC, and Hang Seng Bank reporting better-than-expected half-year results, driven by strong non-interest income, despite ongoing risks in the banking sector [1] Group 1: Stock Performance - Standard Chartered Group (02888) increased by 4.09%, trading at 147.7 HKD - East Asia Bank (00023) rose by 2.32%, trading at 12.78 HKD - HSBC Holdings (00005) gained 1.96%, trading at 98.9 HKD - Hang Seng Bank (00011) increased by 1.77%, trading at 115.1 HKD [1] Group 2: Financial Performance - HSBC and Standard Chartered reported better-than-expected results after excluding non-recurring items, with strong non-interest income supporting revenue growth [1] - However, the overall risk in the Hong Kong banking sector remains, with low HIBOR leading to a decline in interest margins, negatively impacting net interest income in Q2 [1] Group 3: Credit Demand and Real Estate - Hong Kong's credit demand remains weak, with both Standard Chartered and HSBC experiencing a quarter-on-quarter contraction in local loans for Q2 [1] - The non-performing loan ratio in Hong Kong's commercial real estate sector has increased quarter-on-quarter, indicating ongoing pressure in the real estate industry [1] Group 4: Currency Intervention - On August 6, the Hong Kong Monetary Authority (HKMA) intervened by buying 8.439 billion HKD due to the Hong Kong dollar reaching the weak end of its peg against the US dollar [1] - The bank's total reserves are expected to decrease to 64.062 billion HKD on August 8, marking the fourth intervention by the HKMA in seven days [1] - The HKMA indicated that further interventions will occur if the weak end of the peg is triggered again, which may gradually increase interbank rates as total reserves decline [1]

Group 1 - Hong Kong bank stocks rose in the afternoon, with Standard Chartered Group up 4.09% to HKD 147.7, East Asia Bank up 2.32% to HKD 12.78, HSBC Holdings up 1.96% to HKD 98.9, and Hang Seng Bank up 1.77% to HKD 115.1 [1] - HSBC and Hang Seng reported better-than-expected first-half results, with Standard Chartered and HSBC's non-interest income showing strong performance, supporting revenue growth [1] - However, overall risks in the Hong Kong banking sector remain, with low HIBOR leading to a decline in interest margins, negatively impacting net interest income in Q2 [1] Group 2 - Local loan demand in Hong Kong remains weak, with both Standard Chartered and HSBC experiencing a quarter-on-quarter contraction in local loans in Q2 [1] - The non-performing loan ratio in Hong Kong's commercial real estate sector has increased quarter-on-quarter, indicating ongoing pressure in the real estate industry [1] - On August 6, the Hong Kong Monetary Authority intervened by buying HKD 8.439 billion due to the HKD/USD exchange rate touching the weak end of the peg, marking the fourth intervention in seven days [1]

Core Viewpoint - On August 6, eight Hong Kong-listed companies conducted share buybacks, totaling 9.92 million shares and an amount of 79.68 million HKD [1][2]. Group 1: Buyback Details - Xinyi Glass repurchased 6.23 million shares for 49.73 million HKD, with a highest price of 8.080 HKD and a lowest price of 7.820 HKD, marking a total buyback amount of 49.73 million HKD for the year [1][2]. - Hang Seng Bank repurchased 200,000 shares for 22.63 million HKD, with a highest price of 113.600 HKD and a lowest price of 112.800 HKD, totaling 90.62 million HKD in buybacks for the year [1][2]. - Jieli Trading repurchased 2 million shares for 2.75 million HKD, with a highest price of 1.390 HKD and a lowest price of 1.350 HKD, accumulating 36.16 million HKD in buybacks for the year [1][2]. Group 2: Comparative Analysis - In terms of buyback amount, Xinyi Glass led with 49.73 million HKD, followed by Hang Seng Bank with 22.63 million HKD, and Jieli Trading among the top [1][2]. - Regarding buyback volume, Xinyi Glass also had the highest with 6.23 million shares, followed by Jieli Trading with 2 million shares and HYPEBEAST with 957,600 shares [1][2]. Group 3: Year-to-Date Buyback Totals - Xinyi Glass's total buyback amount for the year stands at 49.73 million HKD, while Hang Seng Bank has repurchased shares totaling 90.62 million HKD [1][2]. - Jieli Trading's cumulative buyback amount for the year is 36.16 million HKD, and Miniso has repurchased shares totaling 322.64 million HKD [2].

8月6日，共8只港股获公司回购，2只个股回购金额超千万港元。其中，信义玻璃、恒生银行、捷利交易 宝回购金额最大，分别获公司回购4973.25万港元、2263.47万港元、274.8万港元。截至8月6日，今年已 有216只港股获公司回购，41只个股年内累计回购金额超亿港元。其中，腾讯控股、汇丰控股、友邦保 险年内累计回购金额最大，分别获公司回购400.43亿港元、214.22亿港元、176.93亿港元。 本文源自：金融界AI电报 ...

Summary of Key Points Core Viewpoint - Several companies, including Xinyi Glass, Hang Seng Bank, and Vitasoy International, conducted share buybacks on August 6, 2025, with Xinyi Glass having the largest buyback amount of 49.73 million yuan for 6.227 million shares [1]. Group 1: Buyback Details - Xinyi Glass (00868) repurchased 6.227 million shares for 49.73 million yuan, representing 0.143% of its total share capital [2]. - Hang Seng Bank (00011) repurchased 200,000 shares for 22.63 million yuan, accounting for 0.042% of its total share capital [2]. - Jieli Trading (08017) repurchased 2 million shares for 2.748 million yuan, which is 8.150% of its total share capital [2]. - Yuan Zheng Technology (02488) repurchased 202,500 shares for 2.4993 million yuan, representing 0.394% of its total share capital [2]. - Vitasoy International (00345) repurchased 174,000 shares for 1.6112 million yuan, accounting for 2.205% of its total share capital [2]. - Miniso (09896) repurchased 4.6 million shares for 174,700 yuan, which is 0.294% of its total share capital [2]. - HYPEBEAST (00150) repurchased 957,600 shares for 152,400 yuan, representing 0.599% of its total share capital [2]. - International Home Retail (01373) repurchased 150,000 shares for 12,980 yuan, accounting for 0.410% of its total share capital [2].

Core Viewpoint - Hang Seng Bank has been actively repurchasing its shares, indicating a strategy to support its stock price amid recent declines [2] Summary by Category Share Buyback Activity - On August 6, Hang Seng Bank repurchased 200,000 shares at prices ranging from HKD 112.800 to HKD 113.600, totaling HKD 22.6347 million [2] - The stock closed at HKD 113.100 on the same day, reflecting a decrease of 0.44% with a total trading volume of HKD 343 million [2] - Since August 1, the bank has conducted share buybacks for four consecutive days, acquiring a total of 800,000 shares for a cumulative amount of HKD 90.6157 million [2] - During this period, the stock has experienced a total decline of 1.31% [2] Buyback Details - The buyback details for the past four days are as follows: - August 6: 20,000 shares at a maximum price of HKD 113.600 and a minimum price of HKD 112.800, totaling HKD 22.6347 million [2] - August 5: 20,000 shares at a maximum price of HKD 114.200 and a minimum price of HKD 113.100, totaling HKD 22.7170 million [2] - August 4: 20,000 shares at a maximum price of HKD 114.000 and a minimum price of HKD 111.900, totaling HKD 22.6719 million [2] - August 1: 20,000 shares at a maximum price of HKD 114.300 and a minimum price of HKD 112.400, totaling HKD 22.5922 million [2]

Performance Highlights - BeiGene (06160.HK) reported a revenue of 17.518 billion yuan for the first half of the year, a year-on-year increase of 46%; product revenue was 17.36 billion yuan, up 45.8%; net profit was 450 million yuan, turning from loss to profit [2] - Uni-President China (00220.HK) achieved approximately 17.087 billion yuan in revenue for the first half, a year-on-year increase of 10.6%; net profit was about 1.287 billion yuan, up 33.2% [2] - Zhiyu City Technology (09911.HK) announced a positive profit forecast, expecting mid-term revenue of approximately 3.135 to 3.215 billion yuan, a year-on-year increase of about 38.0% to 41.5%; net profit is expected to be around 470 to 510 million yuan, a year-on-year growth of approximately 108.9% to 126.7% [2] Earnings Forecasts - New World Development Company (00086.HK) expects mid-term net profit to increase to no less than 800 million HKD year-on-year [3] - Weizhi Jinkou (02003.HK) anticipates mid-term net profit exceeding 200 million HKD, a significant increase year-on-year [3] - Wing Chan Industrial (01596.HK) forecasts mid-term net profit of approximately 48.7 million HKD, turning from loss to profit [3] - Huaxian Optoelectronics (00334.HK) expects mid-term net profit to exceed 48.8 million HKD, a year-on-year increase of over 600% [3] - Maifushi (02556.HK) predicts mid-term net profit of approximately 31.8 to 41 million HKD, turning from loss to profit [4] - Xinwei Medical-B (06609.HK) expects mid-term net profit to exceed 40 million HKD, turning from loss to profit [5] - China Nuclear Technology (00611.HK) anticipates mid-term net profit growth of over 15% [6] Earnings Warnings - Hongxing Printing Group (00450.HK) expects mid-term net loss of approximately 49 million HKD, a significant increase year-on-year [7] - Zhongyu Land (01224.HK) forecasts mid-term net loss of approximately 40 million HKD, turning from profit to loss [7] - Beihai Group (00701.HK) anticipates mid-term net loss of 36 to 40 million HKD [8] Real Estate Sales Data - China Overseas Development (00688.HK) reported cumulative contract property sales of approximately 132 billion yuan for the first seven months, a year-on-year decrease of 18.3% [9] - Yuexiu Property (00123.HK) achieved cumulative contract sales of approximately 67.506 billion yuan for the first seven months, a year-on-year increase of about 11.7% [9] - Poly Property Group (00119.HK) reported contract sales of approximately 29.5 billion yuan for the first seven months, a year-on-year decrease of 13.49% [10] - China Overseas Hongyang Group (00081.HK) reported cumulative contract sales of 18.649 billion yuan for the first seven months, a year-on-year decrease of 12.2% [10] - Jindi Commercial Real Estate (00535.HK) reported cumulative contract sales of approximately 6.98 billion yuan for the first seven months, a year-on-year decrease of 37.37% [10] - Agile Group (03383.HK) reported pre-sale amount of approximately 5.69 billion yuan for the first seven months [11] - Hongyang Real Estate (01996.HK) reported cumulative contract sales of 3.208 billion yuan for the first seven months, a year-on-year decrease of 41.6% [12] - Zhengrong Real Estate (06158.HK) reported cumulative contract sales of approximately 2.701 billion yuan for the first seven months, a year-on-year decrease of 30.6% [12] - Jingrui Holdings (01862.HK) reported cumulative contract sales of approximately 571 million yuan for the first seven months, a year-on-year decrease of 52.54% [13] Company News - CITIC Securities (06030.HK) reported that its subsidiary, Huaxia Fund, achieved revenue of 4.258 billion yuan and net profit of 1.123 billion yuan in the first half, with assets under management totaling 285.1237 billion yuan [14] - Xinyi International (00732.HK) reported a cumulative operating revenue of approximately 9.566 billion HKD for the first seven months, a year-on-year decrease of about 5.3% [15] - Heng Rui Pharmaceutical (01276.HK) received orphan drug designation from the US FDA for its injection of Rikan Trastuzumab combined with Adebali for gastric cancer or gastroesophageal junction adenocarcinoma indications [15] - Fuhong Hanlin (02696.HK) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanlikang® for active renal glomerulonephritis in China [15] - China Biopharmaceutical (01177.HK) announced that its self-developed TQ05105 (JAK/ROCK inhibitor) has been included in the breakthrough therapy designation program for the treatment of chronic graft-versus-host disease [15] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.65 billion HKD worth of about 1.714 million shares at a price of 95.8 to 96.75 HKD [16] - Hang Seng Bank (00011.HK) spent approximately 22.6347 million HKD to repurchase 200,000 shares at a price of 112.8 to 113.6 HKD [17] - Yum China (09987.HK) repurchased approximately 6.264 million HKD worth of 16,800 shares at a price of 369.8 to 376 HKD [17]